Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Comment by MartianMarvinon Dec 23, 2024 1:53pm

RE:RE:Epidiolex ANDA.

What's this nonsense you're chattering on about again Butter?  You think that a delay of days or weeks means something with this....lol..... A bunch of litigants settled, the partner of ...more  
Post by subaru1on Dec 23, 2024 11:25am

Speculation

Since Mr. Pidduck is there speculation has been on the air and nothing has been realized, almost 2 years now and the stock keep his historic low at $0,06 oh he said the stock worth $0,15 so he is not ...more  
Post by corvette67on Dec 23, 2024 10:40am

out

Sold last 100k, all being traded on other exchanges. Now it can go up for you,. Good luck and best wishes.
Post by alleyesonmeon Dec 22, 2024 10:56pm

Comparable.

Brain bio, similar business to MPL, similar assets/revenue, debt free, trading in euros..market cap converted into cdn, 123m...if labs had the same valuation fully diluted we would sit at .28c share.. ...more  
Comment by alleyesonmeon Dec 22, 2024 9:55pm

RE:Epidiolex ANDA.

Interestingly, typo, Abbreviated New Drug Application (ANDA) submitted to the FDA in September 2023 ...should read 2022..furthermore..Jazz did not file suit until January 3rd 2023. ANDA ...more  
Post by alleyesonmeon Dec 22, 2024 9:30pm

Epidiolex ANDA.

US FDA Status Update MediPharm completed a US FDA five day in-person inspection from November 21 to 25, 2022. This was initiated in relation to MediPharm’s Cannabidiol Active Pharmaceutical ...more  
Comment by Macpooron Dec 21, 2024 2:50pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

Thank you@ Marvin! You might have an answer to my second question@ Why do combined income for both Vivo and LABS under 10 million? I am from Vivo .I remembered Vivo@s income was around 7 or 8 million ...more  
Comment by Macpooron Dec 21, 2024 2:42pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

Thank you  Marvin! You might have an answer to my second question  Why do combined income for both Vivo and LABS under 10 million? I am from Vivo .I remembered Vivo's income was around ...more  
Post by Solid1on Dec 21, 2024 11:59am

Against the machine

Here is another evaluation of studies carried out in Germany that looks very promising  https://www.dgschmerzmedizin.de/news/dgs-pressemitteilungen/detail/news/dgs-schmerzinitiative-fuer-eine ...more  
Comment by Solid1on Dec 20, 2024 1:21pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

The last one should probably be convinced to sell here... he'll be taken over soon anyway :-D as far as the share purchases and sales are concerned, it was probably more left pocket right pocket ...more  
Comment by alleyesonmeon Dec 20, 2024 11:44am

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

How many shares have traded hands over the past two years? 300m?..in the .06-10c range..I wouldn't be happy but a bid at 14c would easily pass..not to mention retailers are never bothered to vote. ...more  
Comment by MartianMarvinon Dec 20, 2024 11:27am

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

LABS doesn't need any more partners?  Have you seen topline lately?  lol.....Stada isn't blowing numbers out of the water and any other channel can be seen as anemic as they..... ps ...more  
Comment by alleyesonmeon Dec 20, 2024 9:43am

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

MPL doesn't need more partners, disclosed; Avicanna, Stada, "global pharmaceutical Corp"(ANDA), "top three largest Brazilian pharmaceutical Corp", Ketania health..20m ...more  
Comment by MartianMarvinon Dec 20, 2024 9:19am

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

I see we have a new entrant trying to dissect the meaning of the sales investor deck.....lol.....you're smarter than that Lem....;)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities